Cellebrite DI Faces Investor Probe After Stock Plunge

Cellebrite DI Ltd. (CLBT) is under investigation by investor representatives following a significant stock price decline. The company's shares fell more than 30% after the release of its second-quarter 2026 financial results, prompting scrutiny.

Law firm Levi & Korsinsky has initiated an inquiry into Cellebrite DI's statements concerning its previous forecasts and related discussions. This action is a response to investor losses incurred due to the substantial stock drop that occurred in mid-August 2026.

The investigation aims to determine if the disclosures and projections made by Cellebrite DI's management were sufficiently accurate and transparent for investors. Specifically, the company's prior public statements will be examined in relation to its actual performance.

Cellebrite DI specializes in digital intelligence solutions. The development of its business and its investor communications are critical to its market valuation. The outcome of this investigation could impact the company's reputation and future financing activities.